For those that haven't seen this and potential investors. This is Dr Andrew Stephens, the Research Group Head, Ovarian Cancer Biomarkers, at Hudson Institute. GLTAH
- Forums
- ASX - By Stock
- Interview with Dr Andrew Stephens at Hudson Institute - Proof-of-Concept Cancer treatment
IVX
invion limited
Add to My Watchlist
7.41%
!
12.5¢

For those that haven't seen this and potential investors. This...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
-0.010(7.41%) |
Mkt cap ! $11.43M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.5¢ | $70 | 561 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 51312 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 0.125 |
3 | 209200 | 0.120 |
2 | 227489 | 0.115 |
2 | 15520 | 0.105 |
4 | 45300 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 50752 | 1 |
0.135 | 10000 | 1 |
0.140 | 25770 | 2 |
0.145 | 92607 | 3 |
0.150 | 142024 | 5 |
Last trade - 10.04am 17/06/2025 (20 minute delay) ? |
Featured News
IVX (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online